Caglar, M. Et Al. 2012. Comparison of 800 and 3700 MBq iodine-131 for the postoperative ablation of thyroid remnant in patients with low-risk differentiated thyroid cancer. Nuclear Medicine Communications , vol.33, no.3 , 268-274.

Caglar, M., Bozkurt, F. M., Akca, C. K., Vargol, S. E., Bayraktar, M., UĞUR, Ö., ... Karaaǧaoǧlu, E.(2012). Comparison of 800 and 3700 MBq iodine-131 for the postoperative ablation of thyroid remnant in patients with low-risk differentiated thyroid cancer. Nuclear Medicine Communications , vol.33, no.3, 268-274.

Caglar, Meltem Et Al. "Comparison of 800 and 3700 MBq iodine-131 for the postoperative ablation of thyroid remnant in patients with low-risk differentiated thyroid cancer," Nuclear Medicine Communications , vol.33, no.3, 268-274, 2012

Caglar, Meltem Et Al. "Comparison of 800 and 3700 MBq iodine-131 for the postoperative ablation of thyroid remnant in patients with low-risk differentiated thyroid cancer." Nuclear Medicine Communications , vol.33, no.3, pp.268-274, 2012

Caglar, M. Et Al. (2012) . "Comparison of 800 and 3700 MBq iodine-131 for the postoperative ablation of thyroid remnant in patients with low-risk differentiated thyroid cancer." Nuclear Medicine Communications , vol.33, no.3, pp.268-274.

@article{article, author={Meltem Caglar Et Al. }, title={Comparison of 800 and 3700 MBq iodine-131 for the postoperative ablation of thyroid remnant in patients with low-risk differentiated thyroid cancer}, journal={Nuclear Medicine Communications}, year=2012, pages={268-274} }